Novel ligands of the neuropeptide receptor hfgan72
CA 2218452 C · Owner: Gellai, Miklos · Inventors: Gellai, Miklos; Wilson, Shelagh; Yanagisawa, Masashi
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Polypeptides of HFGAN72 receptor ligands and polynucleotides encoding the polypeptides are provided. Methods of using these polypeptides to diagnose diseases relating to the under- or over-expression of HFGAN72 receptor ligands are also provided. In addition methods of identifying agonists or antagonists of the interaction of HFGAN72 receptor ligands with the HFGAN72 receptor are provided. Methods of treatment byadministering the identified agonists or antagonists to patients in need thereof are further disclosed.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 16, 1997 and granted December 4, 2001. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended December 16, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 16, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.